Keyphrases
Immunosuppressive Therapy
100%
Immunization
91%
Vaccination
66%
Immunization Status
65%
Pneumococcal Immunization
58%
Vaccination Rate
50%
Dermatologic Surgery
41%
Specialty Care
41%
Pneumococcal Vaccine
41%
Specialty Clinic
41%
Influenza Vaccine
41%
Vaccine Hesitancy
41%
Preventative Medicine
41%
Influenza Vaccination
41%
Intervention Group
41%
Crusted Scabies
41%
IgA Vasculitis (IgAV)
41%
Immunosuppressive Medication
38%
Scabies
30%
Vaccine-preventable Diseases
30%
Influenza Immunization
25%
Dermatologist
21%
Pruritic Rash
18%
Vaccine Uptake
18%
Quality Improvement Project
18%
Resident Continuity Clinic
16%
Quality Improvement Intervention
16%
Clinician-led
16%
COVID-19
16%
Quasi-experimental Design
16%
Unimmunized
15%
Immunization Rates
13%
Population Health
13%
Purpuric
11%
Leukocytoclastic Vasculitis
11%
Papules
11%
Dermatology Clinic
10%
Insurance
10%
Uninsured Patients
10%
Immunization Coverage
8%
Immunocompromised Patients
8%
Immunization Guidelines
8%
Dermatological Patients
8%
Dermatology Visits
8%
Immunosuppressed Population
8%
Flu Season
8%
Full Immunization
8%
Immunization Recommendation
8%
Dermatology Residency Programs
8%
Dermatology Practice
8%
Medicine and Dentistry
Immunosuppressive Treatment
52%
Quality Improvement
46%
Medicine
41%
Dermatological Agent
41%
Influenza Vaccine
41%
Influenza Vaccination
41%
Vaccine Hesitancy
41%
Scabies
41%
IgA Vasculitis
41%
Clinician
19%
Dermatology
18%
Immunosuppressive Drug
18%
Disease
14%
Drug Therapy
14%
Hypersensitivity Angiitis
11%
Immunization Rate
9%
Infection
8%
Biological Therapy
5%
COVID-19
5%
Influenza
5%
Odds Ratio
5%
Nursing and Health Professions
Immunosuppressive Treatment
83%
Total Quality Management
83%
Hospital
47%
Pneumococcal Conjugate Vaccine
41%
Dermatological Agent
41%
Immunosuppressive Agent
22%
Drug Therapy
18%
Continuity Clinics
13%
Disease
11%
Infection
8%
Vaccination Coverage
6%
Private Practice
6%
Skin Disease
6%
Hospital Planning
6%
